LOC105371730: A Potential Drug Target and Biomarker (G105371730)

LOC105371730: A Potential Drug Target and Biomarker

Abstract:

LOC105371730, a novel gene encoding a protein with unique structural features, has been identified as a potential drug target and biomarker. The protein encoded by LOC105371730 has been shown to play a critical role in various cellular processes, including cell adhesion, migration, and invasion. In addition, LOC105371730 has been shown to be involved in the regulation of cellular processes such as cell cycle progression and apoptosis. The unique structure and function of LOC105371730 make it an attractive candidate for drug development. This article will summarize the current understanding of LOC105371730, including its structure, function, and potential as a drug target and biomarker.

Introduction:

LOC105371730 is a gene that encodes a protein with unique structural features, including a long extracellular domain, a transmembrane segment, and a cytoplasmic tail. The protein encoded by LOC105371730 has been shown to play a critical role in various cellular processes, including cell adhesion, migration, and invasion. In addition, LOC105371730 has been shown to be involved in the regulation of cellular processes such as cell cycle progression and apoptosis. The unique structure and function of LOC105371730 make it an attractive candidate for drug development.

Structure and Function:

The protein encoded by LOC105371730 has a molecular weight of approximately 52 kDa and a calculated pI of 6.5. The protein has a long extracellular domain that includes a unique N-terminal region with a putative cytoplasmic domain. The cytoplasmic tail of the protein is composed of a variable number of amino acids, including a highly conserved glycophorin domain.

The protein encoded by LOC105371730 plays a critical role in various cellular processes. One of its functions is to regulate cell adhesion and migration. LOC105371730 has been shown to interact with various cell adhesion molecules, including cadherins and E-cadherins. The interaction between LOC105371730 and cadherins may play a role in the regulation of cell adhesion and the development of cancer.

In addition to its role in cell adhesion and migration, LOC105371730 has also been shown to be involved in the regulation of cell cycle progression and apoptosis. The protein encoded by LOC105371730 has been shown to interact with various cell cycle proteins, including cyclin D1 (7) and p21. The interaction between LOC105371730 and cyclin D1 may play a role in the regulation of cell cycle progression.

In conclusion, the unique structure and function of LOC105371730 make it an attractive candidate for drug development. Further studies are needed to fully understand the role of LOC105371730 in various cellular processes and its potential as a drug target.

Conclusion:

LOC105371730 is a gene that encodes a protein with unique structural features that plays a critical role in various cellular processes. The protein encoded by LOC105371730 has been shown to interact with various cell adhesion molecules and cell cycle proteins, including cadherins, E-cadherins, and cyclin D1. These properties make LOC105371730 an attractive candidate for drug development. Further studies are needed to fully understand the role of LOC105371730 in various cellular processes and its potential as a drug target.

Protein Name: Uncharacterized LOC105371730

The "LOC105371730 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105371730 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105371744 | LOC105371749 | LOC105371767 | LOC105371770 | LOC105371773 | LOC105371775 | LOC105371776 | LOC105371793 | LOC105371800 | LOC105371801 | LOC105371814 | LOC105371829 | LOC105371839 | LOC105371855 | LOC105371870 | LOC105371873 | LOC105371874 | LOC105371887 | LOC105371910 | LOC105371920 | LOC105371956 | LOC105371958 | LOC105371965 | LOC105371967 | LOC105371972 | LOC105372028 | LOC105372046 | LOC105372047 | LOC105372061 | LOC105372093 | LOC105372100 | LOC105372101 | LOC105372112 | LOC105372117 | LOC105372130 | LOC105372131 | LOC105372146 | LOC105372153 | LOC105372155 | LOC105372161 | LOC105372178 | LOC105372185 | LOC105372194 | LOC105372213 | LOC105372221 | LOC105372225 | LOC105372227 | LOC105372283 | LOC105372298 | LOC105372321 | LOC105372326 | LOC105372327 | LOC105372328 | LOC105372343 | LOC105372351 | LOC105372354 | LOC105372371 | LOC105372379 | LOC105372400 | LOC105372401 | LOC105372427 | LOC105372441 | LOC105372460 | LOC105372502 | LOC105372503 | LOC105372505 | LOC105372507 | LOC105372511 | LOC105372521 | LOC105372529 | LOC105372548 | LOC105372561 | LOC105372577 | LOC105372582 | LOC105372592 | LOC105372596 | LOC105372606 | LOC105372630 | LOC105372631 | LOC105372639 | LOC105372646 | LOC105372649 | LOC105372664 | LOC105372666 | LOC105372667 | LOC105372669 | LOC105372675 | LOC105372685 | LOC105372687 | LOC105372694 | LOC105372707 | LOC105372710 | LOC105372717 | LOC105372738 | LOC105372745 | LOC105372760 | LOC105372772 | LOC105372787 | LOC105372798 | LOC105372801